AVITA MEDICAL INC. - Announcements

Market Cap $167.8M Add to my watchlist

Healthcare Biotechnology

AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a... AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators. RECELL is used for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. The platform technology of the RECELL System enables a thin split-thickness skin sample from the patient to be processed and prepared, producing an autologous cellular suspension called Spray-On Skin Cells. These Spray-On Skin Cells are prepared at the point of care in as little as 30 minutes, providing a new way to treat thermal burn wounds and full-thickness skin defects.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AVH	Final Director's Interest Notice - Michael Perry		20/12/22	251.42KB	Share
AVH	Change of Director's Interest Notice - Suzanne Crowe		19/12/22	245.04KB	Share
AVH	Change of Director's Interest Notice - Louis Panaccio		19/12/22	266.97KB	Share
AVH	Change of Director's Interest Notice - Jeremy Curnock Cook		19/12/22	244.25KB	Share
AVH	Change of Director's Interest Notice - James Corbett		19/12/22	245.44KB	Share
AVH	Change of Director's Interest Notice - Jan Stern Reed		19/12/22	244.11KB	Share
AVH	AVITA Medical Submits FDA PMA Application for Vitiligo		19/12/22	159.54KB	Share
AVH	Notification regarding unquoted securities - AVH		16/12/22	41.5KB	Share
AVH	Results of 2022 Annual Meeting of Stockholders		13/12/22	288.12KB	Share
AVH	2022 ASM Chairman Script		12/12/22	198.2KB	Share
AVH	2022 Annual Meeting of Stockholders Presentation		12/12/22	1.84MB	Share
AVH	AVITA Medical Submits PMA Supplement for Soft Tissue Repair		12/12/22	162.99KB	Share
AVH	Statement of CDIs on issue - AVH		06/12/22	26.03KB	Share
AVH	Notification of cessation of securities - AVH		02/12/22	25.52KB	Share
AVH	Change of Director's Interest Notice - Michael Perry		29/11/22	236KB	Share
AVH	Notice under section 708A(5)(e) of the Corporations Act		29/11/22	203.48KB	Share
AVH	Notification regarding unquoted securities - AVH		29/11/22	26.81KB	Share
AVH	AVITA Medical Melbourne Investor Briefing		22/11/22	291.08KB	Share
AVH	AVITA Medical at the Piper Sandler Healthcare Conference		22/11/22	157.25KB	Share
AVH	AVITA Medical to Host Investor Webinar Briefing		17/11/22	138.44KB	Share
AVH	Change of Director's Interest Notice - Michael Perry		11/11/22	236.03KB	Share
AVH	Quarterly Financial Report Form 10-Q	PRICE SENSITIVE	11/11/22	1.32MB	Share
AVH	AVITA Medical Reports Third Quarter 2022 Financial Results	PRICE SENSITIVE	11/11/22	385.77KB	Share
AVH	Co-Primary Endpoints Met in RECELL Soft Tissue Repair Trial	PRICE SENSITIVE	10/11/22	117.21KB	Share
AVH	Statement of CDIs on issue - AVH		07/11/22	26.26KB	Share
AVH	Notification of cessation of securities - AVH		07/11/22	25.13KB	Share
AVH	FDA Grants Breakthrough Device Designations to RECELL System		04/11/22	155.47KB	Share
AVH	AVITA Medical to Announce Third Quarter Financial Results		21/10/22	169.94KB	Share
AVH	Definitive Proxy Statement		20/10/22	1.66MB	Share
AVH	Notification regarding unquoted securities - AVH		11/10/22	30.2KB	Share
AVH	Statement of CDIs on issue - AVH		07/10/22	25.74KB	Share
AVH	Notification of cessation of securities - AVH		04/10/22	31.18KB	Share
AVH	Form 8-K Material terms of CEO's Employment Agreement		30/09/22	576.85KB	Share
AVH	AVITA Medical Appoints James Corbett as CEO	PRICE SENSITIVE	29/09/22	236.13KB	Share
AVH	Ceasing to be a substantial holder		20/09/22	579.96KB	Share
AVH	AVITA Medical Investor Webinar Briefing Deck		20/09/22	1.55MB	Share
AVH	Investor Webinar Briefing		14/09/22	144.95KB	Share
AVH	Positive Trial Results Treating Stable Vitiligo With RECELL		13/09/22	178.85KB	Share
AVH	Change of Director's Interest Notice - Michael Perry		09/09/22	238.23KB	Share
AVH	Notice under section 708A(5)(e) of the Corporations Act		09/09/22	175KB	Share
AVH	Notification regarding unquoted securities - AVH		09/09/22	27.66KB	Share
AVH	Statement of CDIs on issue - AVH		07/09/22	26.38KB	Share
AVH	Notification of cessation of securities - AVH		07/09/22	26.89KB	Share
AVH	RECELL Insurance Coverage Begins in Japan for Acute Burns		02/09/22	173.68KB	Share
AVH	AVITA Medical Corporate Deck August 2022	PRICE SENSITIVE	30/08/22	3.28MB	Share
AVH	Notice under section 708A(5)(e) of the Corporations Act		19/08/22	156.9KB	Share
AVH	Notification regarding unquoted securities - AVH		19/08/22	27.84KB	Share
AVH	RECELL Presentations at Laser & Cosmetic Surgery Meeting		18/08/22	176.18KB	Share
AVH	Half Year Financial Report Form 10-Q	PRICE SENSITIVE	12/08/22	508.16KB	Share
AVH	AVITA Medical Topline Results from Soft-Tissue Pivotal Trial	PRICE SENSITIVE	12/08/22	174.34KB	Share
AVH	AVITA Medical Reports Second Quarter 2022 Financial Results	PRICE SENSITIVE	12/08/22	293.69KB	Share
AVH	Statement of CDIs on issue - AVH		05/08/22	25.6KB	Share
AVH	Notification of cessation of securities - AVH		03/08/22	23.33KB	Share
AVH	AVITA to Announce Second Quarter 2022 Financial Results		26/07/22	134.07KB	Share
AVH	Notification regarding unquoted securities - AVH		25/07/22	29.25KB	Share
AVH	Ceasing to be a substantial holder		22/07/22	146.74KB	Share
AVH	Notification regarding unquoted securities - AVH		11/07/22	35.17KB	Share
AVH	Statement of CDIs on issue - AVH		06/07/22	25.36KB	Share
AVH	Notification of cessation of securities - AVH		01/07/22	24.86KB	Share
AVH	Change of Director's Interest Notice - Michael Perry		10/06/22	240.84KB	Share
AVH	Notice under section 708A(5)(e) of the Corporations Act		10/06/22	187.19KB	Share
AVH	Notification regarding unquoted securities - AVH		10/06/22	27.2KB	Share
AVH	Statement of CDIs on issue - AVH		07/06/22	25.84KB	Share
AVH	Notification of cessation of securities - AVH		03/06/22	24.89KB	Share
AVH	AVITA Medical Investor Webinar		02/06/22	93.98KB	Share
AVH	Quarterly Financial Report (Form 10-Q)	PRICE SENSITIVE	13/05/22	217.37KB	Share
AVH	AVITA Medical Corporate Presentation May 2022	PRICE SENSITIVE	12/05/22	4.94MB	Share
AVH	RECELL System to be Presented at SCALE Dermatology Meeting		10/05/22	151.67KB	Share
AVH	Statement of CDIs on issue - AVH		06/05/22	25.77KB	Share
AVH	Final Director's Interest Notice - Louis Drapeau		06/05/22	248.11KB	Share
AVH	Notification of cessation of securities - AVH		06/05/22	25.47KB	Share
AVH	AVITA to Announce First Quarter 2022 Financial Results		29/04/22	133.25KB	Share
AVH	AVH - Resignation of Louis Drapeau from Board of Directors		22/04/22	174.29KB	Share
AVH	Notification regarding unquoted securities - AVH		12/04/22	33.2KB	Share
AVH	Statement of CDIs on issue - AVH		08/04/22	24.09KB	Share
AVH	Notification of cessation of securities - AVH		07/04/22	25.46KB	Share
AVH	RECELL Data to be Presented at American Burn Assoc. Meeting		05/04/22	177.81KB	Share
AVH	RECELL Vitiligo Protocol Presentation at Vitiligo Symposium		24/03/22	173.53KB	Share
AVH	AVITA Medical Webinar Alert 11am (AEDT) 24 March 2022		22/03/22	126.08KB	Share
AVH	AVITA Medical Announces Modification of BARDA Contract		22/03/22	160.31KB	Share
AVH	Notification regarding unquoted securities - AVH		10/03/22	26.7KB	Share
AVH	Cowen Conference Presentation		08/03/22	3.26MB	Share
AVH	Statement of CDIs on issue - AVH		07/03/22	24.07KB	Share
AVH	Notification of cessation of securities - AVH		03/03/22	22.75KB	Share
AVH	Notice under section 708A(5)(e) of the Corporations Act		03/03/22	175.49KB	Share
AVH	Change of Director's Interest Notice-Michael Perry		03/03/22	598.23KB	Share
AVH	Notification regarding unquoted securities - AVH		03/03/22	30.15KB	Share
AVH	AVITA Medical signs agreement with Premier Inc	PRICE SENSITIVE	03/03/22	187.35KB	Share
AVH	Appendix 4G and Corporate Governance Statement		01/03/22	533.52KB	Share
AVH	Financial Results December 21 Quarter and Transition Period	PRICE SENSITIVE	01/03/22	299.49KB	Share
AVH	Appendix 4E and Preliminary Final Report (Form 10-K)	PRICE SENSITIVE	01/03/22	2.62MB	Share
AVH	AVITA Medical Corporate Presentation	PRICE SENSITIVE	28/02/22	3.26MB	Share
AVH	AVITA (AVH) Announces RECELL Receives Japan PMDA Approval		24/02/22	151.05KB	Share
AVH	AVITA Medical to Present at Cowen Health Care Conference		24/02/22	132.65KB	Share
AVH	AVITA - Approval of New RECELL System Improved Ease of Use	PRICE SENSITIVE	18/02/22	151.85KB	Share
AVH	AVITA (AVH) Announces July 1- Dec 31, 2021 Financial Results		16/02/22	134.44KB	Share
AVH	Statement of CDIs on issue - AVH		04/02/22	24.1KB	Share
AVH	AVITA Medical to Present at the BTIG MedTech Conference		02/02/22	132.72KB	Share
AVH	Notification of cessation of securities - AVH		01/02/22	22.74KB	Share
AVH	Substantial Holder Notice		25/01/22	146.88KB	Share

AVH Final Director's Interest Notice - Michael Perry
20/12/22		251.42KB	Share
AVH Change of Director's Interest Notice - Suzanne Crowe
19/12/22		245.04KB	Share
AVH Change of Director's Interest Notice - Louis Panaccio
19/12/22		266.97KB	Share
AVH Change of Director's Interest Notice - Jeremy Curnock Cook
19/12/22		244.25KB	Share
AVH Change of Director's Interest Notice - James Corbett
19/12/22		245.44KB	Share
AVH Change of Director's Interest Notice - Jan Stern Reed
19/12/22		244.11KB	Share
AVH AVITA Medical Submits FDA PMA Application for Vitiligo
19/12/22		159.54KB	Share
AVH Notification regarding unquoted securities - AVH
16/12/22		41.5KB	Share
AVH Results of 2022 Annual Meeting of Stockholders
13/12/22		288.12KB	Share
AVH 2022 ASM Chairman Script
12/12/22		198.2KB	Share
AVH 2022 Annual Meeting of Stockholders Presentation
12/12/22		1.84MB	Share
AVH AVITA Medical Submits PMA Supplement for Soft Tissue Repair
12/12/22		162.99KB	Share
AVH Statement of CDIs on issue - AVH
06/12/22		26.03KB	Share
AVH Notification of cessation of securities - AVH
02/12/22		25.52KB	Share
AVH Change of Director's Interest Notice - Michael Perry
29/11/22		236KB	Share
AVH Notice under section 708A(5)(e) of the Corporations Act
29/11/22		203.48KB	Share
AVH Notification regarding unquoted securities - AVH
29/11/22		26.81KB	Share
AVH AVITA Medical Melbourne Investor Briefing
22/11/22		291.08KB	Share
AVH AVITA Medical at the Piper Sandler Healthcare Conference
22/11/22		157.25KB	Share
AVH AVITA Medical to Host Investor Webinar Briefing
17/11/22		138.44KB	Share
AVH Change of Director's Interest Notice - Michael Perry
11/11/22		236.03KB	Share
AVH Quarterly Financial Report Form 10-Q
11/11/22	PRICE SENSITIVE	1.32MB	Share
AVH AVITA Medical Reports Third Quarter 2022 Financial Results
11/11/22	PRICE SENSITIVE	385.77KB	Share
AVH Co-Primary Endpoints Met in RECELL Soft Tissue Repair Trial
10/11/22	PRICE SENSITIVE	117.21KB	Share
AVH Statement of CDIs on issue - AVH
07/11/22		26.26KB	Share
AVH Notification of cessation of securities - AVH
07/11/22		25.13KB	Share
AVH FDA Grants Breakthrough Device Designations to RECELL System
04/11/22		155.47KB	Share
AVH AVITA Medical to Announce Third Quarter Financial Results
21/10/22		169.94KB	Share
AVH Definitive Proxy Statement
20/10/22		1.66MB	Share
AVH Notification regarding unquoted securities - AVH
11/10/22		30.2KB	Share
AVH Statement of CDIs on issue - AVH
07/10/22		25.74KB	Share
AVH Notification of cessation of securities - AVH
04/10/22		31.18KB	Share
AVH Form 8-K Material terms of CEO's Employment Agreement
30/09/22		576.85KB	Share
AVH AVITA Medical Appoints James Corbett as CEO
29/09/22	PRICE SENSITIVE	236.13KB	Share
AVH Ceasing to be a substantial holder
20/09/22		579.96KB	Share
AVH AVITA Medical Investor Webinar Briefing Deck
20/09/22		1.55MB	Share
AVH Investor Webinar Briefing
14/09/22		144.95KB	Share
AVH Positive Trial Results Treating Stable Vitiligo With RECELL
13/09/22		178.85KB	Share
AVH Change of Director's Interest Notice - Michael Perry
09/09/22		238.23KB	Share
AVH Notice under section 708A(5)(e) of the Corporations Act
09/09/22		175KB	Share
AVH Notification regarding unquoted securities - AVH
09/09/22		27.66KB	Share
AVH Statement of CDIs on issue - AVH
07/09/22		26.38KB	Share
AVH Notification of cessation of securities - AVH
07/09/22		26.89KB	Share
AVH RECELL Insurance Coverage Begins in Japan for Acute Burns
02/09/22		173.68KB	Share
AVH AVITA Medical Corporate Deck August 2022
30/08/22	PRICE SENSITIVE	3.28MB	Share
AVH Notice under section 708A(5)(e) of the Corporations Act
19/08/22		156.9KB	Share
AVH Notification regarding unquoted securities - AVH
19/08/22		27.84KB	Share
AVH RECELL Presentations at Laser & Cosmetic Surgery Meeting
18/08/22		176.18KB	Share
AVH Half Year Financial Report Form 10-Q
12/08/22	PRICE SENSITIVE	508.16KB	Share
AVH AVITA Medical Topline Results from Soft-Tissue Pivotal Trial
12/08/22	PRICE SENSITIVE	174.34KB	Share
AVH AVITA Medical Reports Second Quarter 2022 Financial Results
12/08/22	PRICE SENSITIVE	293.69KB	Share
AVH Statement of CDIs on issue - AVH
05/08/22		25.6KB	Share
AVH Notification of cessation of securities - AVH
03/08/22		23.33KB	Share
AVH AVITA to Announce Second Quarter 2022 Financial Results
26/07/22		134.07KB	Share
AVH Notification regarding unquoted securities - AVH
25/07/22		29.25KB	Share
AVH Ceasing to be a substantial holder
22/07/22		146.74KB	Share
AVH Notification regarding unquoted securities - AVH
11/07/22		35.17KB	Share
AVH Statement of CDIs on issue - AVH
06/07/22		25.36KB	Share
AVH Notification of cessation of securities - AVH
01/07/22		24.86KB	Share
AVH Change of Director's Interest Notice - Michael Perry
10/06/22		240.84KB	Share
AVH Notice under section 708A(5)(e) of the Corporations Act
10/06/22		187.19KB	Share
AVH Notification regarding unquoted securities - AVH
10/06/22		27.2KB	Share
AVH Statement of CDIs on issue - AVH
07/06/22		25.84KB	Share
AVH Notification of cessation of securities - AVH
03/06/22		24.89KB	Share
AVH AVITA Medical Investor Webinar
02/06/22		93.98KB	Share
AVH Quarterly Financial Report (Form 10-Q)
13/05/22	PRICE SENSITIVE	217.37KB	Share
AVH AVITA Medical Corporate Presentation May 2022
12/05/22	PRICE SENSITIVE	4.94MB	Share
AVH RECELL System to be Presented at SCALE Dermatology Meeting
10/05/22		151.67KB	Share
AVH Statement of CDIs on issue - AVH
06/05/22		25.77KB	Share
AVH Final Director's Interest Notice - Louis Drapeau
06/05/22		248.11KB	Share
AVH Notification of cessation of securities - AVH
06/05/22		25.47KB	Share
AVH AVITA to Announce First Quarter 2022 Financial Results
29/04/22		133.25KB	Share
AVH AVH - Resignation of Louis Drapeau from Board of Directors
22/04/22		174.29KB	Share
AVH Notification regarding unquoted securities - AVH
12/04/22		33.2KB	Share
AVH Statement of CDIs on issue - AVH
08/04/22		24.09KB	Share
AVH Notification of cessation of securities - AVH
07/04/22		25.46KB	Share
AVH RECELL Data to be Presented at American Burn Assoc. Meeting
05/04/22		177.81KB	Share
AVH RECELL Vitiligo Protocol Presentation at Vitiligo Symposium
24/03/22		173.53KB	Share
AVH AVITA Medical Webinar Alert 11am (AEDT) 24 March 2022
22/03/22		126.08KB	Share
AVH AVITA Medical Announces Modification of BARDA Contract
22/03/22		160.31KB	Share
AVH Notification regarding unquoted securities - AVH
10/03/22		26.7KB	Share
AVH Cowen Conference Presentation
08/03/22		3.26MB	Share
AVH Statement of CDIs on issue - AVH
07/03/22		24.07KB	Share
AVH Notification of cessation of securities - AVH
03/03/22		22.75KB	Share
AVH Notice under section 708A(5)(e) of the Corporations Act
03/03/22		175.49KB	Share
AVH Change of Director's Interest Notice-Michael Perry
03/03/22		598.23KB	Share
AVH Notification regarding unquoted securities - AVH
03/03/22		30.15KB	Share
AVH AVITA Medical signs agreement with Premier Inc
03/03/22	PRICE SENSITIVE	187.35KB	Share
AVH Appendix 4G and Corporate Governance Statement
01/03/22		533.52KB	Share
AVH Financial Results December 21 Quarter and Transition Period
01/03/22	PRICE SENSITIVE	299.49KB	Share
AVH Appendix 4E and Preliminary Final Report (Form 10-K)
01/03/22	PRICE SENSITIVE	2.62MB	Share
AVH AVITA Medical Corporate Presentation
28/02/22	PRICE SENSITIVE	3.26MB	Share
AVH AVITA (AVH) Announces RECELL Receives Japan PMDA Approval
24/02/22		151.05KB	Share
AVH AVITA Medical to Present at Cowen Health Care Conference
24/02/22		132.65KB	Share
AVH AVITA - Approval of New RECELL System Improved Ease of Use
18/02/22	PRICE SENSITIVE	151.85KB	Share
AVH AVITA (AVH) Announces July 1- Dec 31, 2021 Financial Results
16/02/22		134.44KB	Share
AVH Statement of CDIs on issue - AVH
04/02/22		24.1KB	Share
AVH AVITA Medical to Present at the BTIG MedTech Conference
02/02/22		132.72KB	Share
AVH Notification of cessation of securities - AVH
01/02/22		22.74KB	Share
AVH Substantial Holder Notice
25/01/22		146.88KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last $2.70		Change -0.010(0.37%)		Mkt cap ! $167.8M

Open	High	Low	Value	Volume
$2.73	$2.74	$2.68	$913.8K	336.5K

Buyers (Bids)

No.	Vol.	Price($)
3	3704	$2.69

Sellers (Offers)

Price($)	Vol.	No.
$2.70	10305	2

View Market Depth

No.	Vol.	Price($)
3	3704	2.690
4	11508	2.680
4	7578	2.670
2	852	2.660
3	3375	2.650

Price($)	Vol.	No.
2.700	10305	2
2.710	20118	3
2.720	24650	3
2.730	10000	1
2.740	10000	1

Last trade - 16.10pm 10/05/2024 (20 minute delay)


Last $2.71		Change -0.010 ( 0.90 %)
Open	High	Low	Volume
$2.73	$2.74	$2.68	11334
Last updated 15.59pm 10/05/2024 ?

AVH (ASX) Chart

AVITA MEDICAL INC. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available